EP3355902
COMBINATION OF A PD-1 AXIS BINDING ANTAGONIST AND AN ALK INHIBITOR FOR TREATING ALK-NEGATIVE CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.9.2016EP published:
13.4.2022EP application number:
16779272.0
EPO information:
European Patent Register
Max expiry date:
26.9.2036
Title in English:
COMBINATION OF A PD-1 AXIS BINDING ANTAGONIST AND AN ALK INHIBITOR FOR TREATING ALK-NEGATIVE CANCERLanguage of the patent:
English
Timeline
Today
27.9.2016EP application
13.4.2022EP Publication
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293 Darmstadt, DE
Name:
Pfizer Inc.Address:
235 East 42nd Street, New York, NY 10017, US
Inventor
Name:
LIN, Chia-YangAddress:
Palo Alto, California 94303, US
Name:
PRIOR, Wei Wei WuAddress:
Redwood City, CA 94065, US
Name:
QU, YanAddress:
Half Moon Bay, California 94019, US
Name:
WANG, ChangyuAddress:
Union City, California 94587, US
Priority
Number:
201562235406 PDate:
30.9.2015Country:
US
Number:
201662385430 PDate:
9.9.2016Country:
US
Number:
201662393609 PDate:
12.9.2016Country:
US
Classification
Categories:
A61K 31/439, A61K 31/4545, A61P 35/00